Northwestern Mutual Wealth Management’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
Other funds holding PPH
JSAM
AT
AWC
Northwestern Mutual Wealth Management's PPH Position: Q2 2026 in Review
Northwestern Mutual Wealth Management reduced its VanEck Pharmaceutical ETF (PPH) stake by 42% in Q2 2026, selling an estimated $975K and leaving 13,199 shares worth $1.44M. The position accounts for ﹤0.01% of the portfolio, ranked #1280.
Northwestern Mutual Wealth Management first reported a position in PPH in Q4 2022 and has held it in 15 quarters since. The position peaked at $15.4M in Q3 2024. 148 funds tracked by Wall St. Rank hold PPH as of Q2 2026.
- Northwestern Mutual Wealth Management held 13,199 shares of VanEck Pharmaceutical ETF worth $1.44M as of Q2 2026.
- Northwestern Mutual Wealth Management sold 9,424 VanEck Pharmaceutical ETF shares in Q2 2026, an estimated $975K.
- VanEck Pharmaceutical ETF made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #1280 holding.
- Northwestern Mutual Wealth Management first reported a position in VanEck Pharmaceutical ETF in Q4 2022 and has held it in 15 quarters since.
- Northwestern Mutual Wealth Management's VanEck Pharmaceutical ETF position peaked at $15.4M in Q3 2024.
- 148 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.
Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.